Revenio Group Corporation Stock Exchange Release March 6, 2015 at 09:00
INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER
1,000 new share subscriptions based on the company's 2007C stock options approved by the Board of Directors of Revenio Group Corporation on February 24, 2015, have been entered into the trade register today. The share subscription price under 2007C option rights was 1.69 per share. The subscription period for 2007C options is to June 1, 2016.
After these subscriptions, the number of Revenio Group Corporation's shares and votes will rise to 7,933,078. These increases were recorded in their entirety in the unrestricted shareholders' equity fund.
Revenio Group Corporation has applied for the listing of its new shares on the Nasdaq Helsinki in the same series as the company's existing shares. According to the current estimate, the new shares will be listed on March 9, 2015.
Revenio Group Oyj
Olli-Pekka Salovaara
CEO
For further information, please contact:
President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520
olli-pekka.salovaara@revenio.fi
http://www.revenio.fi
Distribution:
Nasdaq Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi
The Revenio Group in brief
Revenio is a Finnish health tech group whose core business lies in tonometers. The Revenio Health Tech segment comprises the business operations of Icare Finland Oy and Oscare Medical Oy, which specializes in osteoporosis screening and assessment. In addition, Revenio has identified new growth opportunities relating to health tech in which common denominators are screening, follow-up and the global need to make cost savings in health care through preventive measures. Revenio seeks vigorous growth in health technology, both organically and through acquisitions and mergers.
In 2014, the Revenio Group's net sales totaled MEUR 16.0, with its operating margin for continuing operations standing at 27,5%. The Revenio Group Corporation is listed on Nasdaq Helsinki.